OSTEOPOROSIS RISK-FACTORS, GYNECOLOGICAL HISTORY AND FRACTURES IN PERIMENOPAUSAL WOMEN - THE RESULTS OF THE BASE-LINE POSTAL INQUIRY OF THEKUOPIO OSTEOPOROSIS RISK FACTOR AND PREVENTION STUDY
M. Tuppurainen et al., OSTEOPOROSIS RISK-FACTORS, GYNECOLOGICAL HISTORY AND FRACTURES IN PERIMENOPAUSAL WOMEN - THE RESULTS OF THE BASE-LINE POSTAL INQUIRY OF THEKUOPIO OSTEOPOROSIS RISK FACTOR AND PREVENTION STUDY, Maturitas, 17(2), 1993, pp. 89-100
Citations number
31
Categorie Soggetti
Geiatric & Gerontology","Obsetric & Gynecology","Medicine, General & Internal
The Kuopio Osteoporosis Risk Factor and Prevention (OSTPRE) Study exam
ines the risk factors of osteoporosis, the relationship of risk factor
s to bone density and fractures, as well as the possibility to prevent
bone loss by administering certain hormones. The baseline postal enqu
iry in 1989 was sent to all the 14 220 women aged 47-56 years residing
in the Kuopio Province, Finland. The questionnaire included questions
about their gynaecological history, physical exercise and smoking hab
its, calcium intake, body weight and height, history of bone fractures
, health disorders, their current and previous use of drugs, as well a
s their willingness to participate in bone densitometry and in a clini
cal hormone trial. The response rate was 92.8%. In all, 56% reported s
ome previous use of female hormones. Strong contraindications for oest
rogen replacement therapy were found in 9.3% of the women. Almost half
of the respondents reported lack of regular physical exercise, 11.9%
were smokers, and 17.0% reported a calcium intake from milk products o
f less than 500 mg daily. The incidence of fractures increased steadil
y with age. The incidence of premenopausal fractures within the last 1
0 years was 7.65 per 1000 person/years and that of postmenopausal frac
tures was 17.40 per 1000 person/years (P = 0.000). The effect of menop
ause on fracture incidence was stronger than the effect of a 5-year ag
e increase. Of the respondents. 84.4% were willing to participate in b
one densitometry and 68.3% for long-term prevention of osteoporosis wi
th oestrogen.